Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administr… (NCT06975943) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth
Indonesia48 participantsStarted 2024-01-01
Plain-language summary
This randomised clinical trial aims to investigate the effect of daily vaginal progesterone supplementation on pregnancy prolongation and cervical length changes following arrested preterm labor in singleton pregnancies. The study will recruit pregnant women between 28 and 33 weeks of gestational age who had experienced threatened preterm labor at Dr. Soetomo Hospital in Indonesia. Participants will be randomly divided into two groups: a Treatment Group receiving vaginal progesterone therapy and a Control Group receiving standard care without progesterone intervention. The primary outcomes are the prolongation of gestational age until delivery and the changes in cervical length over time. The secondary outcomes are recurrence of threatened preterm labor, mode of delivery, neonatal outcomes, and survival analysis. This study will provide valuable evidence supporting the use of vaginal progesterone as an effective intervention for women at risk of preterm labor and potentially improving maternal and neonatal outcomes in Indonesia and globally. All participants will be provided with detailed information about the study, and their participation will be voluntary. Ethical considerations, including informed consent and data confidentiality, will be strictly adhered to throughout the study.
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Singleton pregnant women who have passed the acute phase of Threatened Preterm Labor that meets the following criteria:
✓. Persistent contractions (2-3 contractions in 10 minutes) accompanied by cervical dilation assessed based on pelvic examination (Vaginal Touche)
✓. Intact amniotic membrane
✓. Cervical dilation ≤ 2 cm
✓. No birth occurs within 2x24 hours since persistent contractions appear.
✓. Age 18-40 years
✓. The gestational age must be between 28 weeks and 33 weeks plus 6 days.
✓. Able to participate, communicate well with researchers, and willing to provide written consent to participate in the study.
Exclusion criteria
✕. Patients with cervical cerclage in this pregnancy
✕. Cervical length is less than 10 mm
What they're measuring
1
Prolongation of Gestation Age
Timeframe: Enrollment and Delivery
2
Changes of Cervical Length
Timeframe: Enrollment, 7th and 14th day after enrollment